Skip to content

Opto-electrical Transvaginal imaging probe for cervical pre-cancer diagnosis

Opto-electrical transvaginal imaging probe for preinvasive cervical cancer diagnosis. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084939
Enrollment
410
Registered
2025-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control Intervention1: Agreeement of opto electric probe high grade lesion with the colposcopic high grade lesion (Swede Score 5): Agreeement of opto electric probe high grade lesion with the colposc

Sponsors

ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age: Above 18 years and up to 75 years 2. Female OPD patients 3. Screen positive patients coming for colposcopy Having any one of the following: a. Pap smear- ASCUS, ASCUS H, LSIL, HSIL b. VIA/VILI Abnormal report c. HPV DNA positive

Exclusion criteria

Exclusion criteria: 1. Post hysterectomy 2. Menstruating at the time of visit 3. Pregnant at the time of visit 4. Active cervicitis or vulvovaginitis 5. Obvious growth in cervix suggestive of cancer

Design outcomes

Primary

MeasureTime frame
1.To see the agreement of opto-electric bimodal transvagi-nal imaging probe to detect high grade lesions with colpo-scopic high grade lesion (Swede colposcopy index more than 5). 2.To determine the diagnostic accuracy of bimodal trans-vaginal multispectral imaging probe in comparison to standard coposcopy to detect premalignant lesions (CIN2 or CIN3 - pathology).Timepoint: The opto-electric probe will freeze by 12 weeks and the recruitment will start from 1st July, 2025.

Secondary

MeasureTime frame
Find the sensitivity and specificity of the opto-electric probe to detect preinvasive cervical lesion.Timepoint: Within 6 months of the completion of the first phase of the trial.

Countries

India

Contacts

Public ContactDr Arpitha A

Jawaharlal Institute of Postgraduate Medical Education and Research

drarpithagynonco@gmail.com9481068681

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026